Windows of Opportunity: Integrated Hepatitis C Programming Approaches for Priority Populations

 

Appendix IV Evaluation results

Evaluation forms were distributed to attendees. The response rate was high at 81% (34/42).

The event was relevant to all attendees. Relevance was assessed through the following indicators:

  • 100% of participants agreed or strongly agreed that the deliberative dialogue was appropriate for them.
  • 100% of participants agreed or strongly agreed that they will use/apply the knowledge gained through this deliberative dialogue in their work.
  • 100% of participants agreed or strongly agreed that the deliberative dialogue was relevant to the work of their organization.

The deliberative dialogue met its overall objectives.

Increased knowledge:

  • 97% of participants agreed or strongly agreed that the deliberative dialogue increased their knowledge of new directions in hepatitis C programming.
  • 100% of participants agreed or strongly agreed that they would recommend that CATIE continue to offer this type of event.

Increased capacity to respond:

  • 100% of participants agreed or strongly agreed that the deliberative dialogue increased their capacity to respond to hepatitis C.

Provided an opportunity to network:

  • 100% of participants agreed or strongly agreed that the deliberative dialogue provided an opportunity to network with others.
  • 97% of participants agreed or strongly agreed that the deliberative dialogue was effective at facilitating multi-region, cross-sectoral collaboration, knowledge sharing and networking among hepatitis C programming leaders.

Provided an opportunity to explore issues and identify priorities:

  • 100% of participants agreed or strongly agreed that the deliberative dialogue was effective at informing priority directions for population-specific hepatitis C programming, services and policy that put s at the centre of an integrated framework.
  • 97% of participants agreed or strongly agreed that the deliberative dialogue was effective at providing guidance to programs across Canada on hepatitis C continuum of care models for specific populations.